<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001701'>Pericarditis</z:hpo> may recur in up to 30 % of adult patients, but recurrent <z:hpo ids='HP_0001701'>pericarditis</z:hpo> is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disease</z:e> in childhood </plain></SENT>
<SENT sid="1" pm="."><plain>The etiology of the initial attack and the causes of recurrences often remain unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Recurrent <z:hpo ids='HP_0001701'>pericarditis</z:hpo> is accompanied by a high morbidity rate and may represent a challenge to the clinician due to problems in management </plain></SENT>
<SENT sid="3" pm="."><plain>Therapeutic strategies are not specific and include <z:chebi fb="2" ids="35475">nonsteroidal antiinflammatory drugs</z:chebi>, <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, immunosuppressive drugs, <z:chebi fb="0" ids="23359">colchicine</z:chebi>, and pericardiectomy </plain></SENT>
<SENT sid="4" pm="."><plain>Controlled trials have demonstrated that <z:chebi fb="0" ids="23359">colchicine</z:chebi> can reduce the recurrent rate of <z:hpo ids='HP_0001701'>pericarditis</z:hpo>, whereas early <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy promotes recurrences </plain></SENT>
<SENT sid="5" pm="."><plain>Anakinra, a recombinant human interleukin-1β receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, is a promising new biologic agent for the treatment of autoinflammatory diseases such as cryopyrinopathies, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor-associated <z:e sem="disease" ids="C0585274" disease_type="Disease or Syndrome" abbrv="">periodic syndrome</z:e>, and <z:e sem="disease" ids="C0020455" disease_type="Disease or Syndrome" abbrv="">hyperimmunoglobulinemia</z:e> D with periodic <z:hpo ids='HP_0001945'>fever</z:hpo> syndrome </plain></SENT>
<SENT sid="6" pm="."><plain>This report describes an 11-year-old boy successfully treated with anakinra for a steroid-dependent recurrent <z:hpo ids='HP_0001701'>pericarditis</z:hpo> unresponsive to conventional treatment </plain></SENT>
</text></document>